With global ageing, delirium has become a common, serious, and costly condition that is a growing challenge for both patients and healthcare professionals. Additionally, it is among the most frequent and consequential complications following major surgery. It is still uncertain whether the prophylactic administration of drugs is an effective strategy to prevent this condition. A recent study aimed to identify which drugs are effective at preventing post-operative delirium in adults over 60 years of age and estimate the effects on morbidity and mortality.
Randomised controlled trials that included participants aged 60 years or older who were undergoing surgery that required general or regional anaesthesia were eligible for inclusion. A total of 158 randomised controlled trials consisting of 41 084 participants, 337 comparison arms, and 52 interventions and placebos were included. The findings were reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses-Network Meta-analyses (PRISMA-NMA) guideline.
The authors found that dexmedetomidine is effective in the prevention of postoperative delirium across surgical specialties, urgency of surgery, and irrespective of the type of anaesthesia. Corticosteroids, melatonin receptor agonists, parecoxib, intranasal insulin, and olanzapine have potential benefits. However, the evidence is of moderate to very low quality; thus, more studies are needed. Most interventions did not affect length of stay, mortality, cognition, or quality of life. In addition, the study notes that reporting of emotional distress and data availability for health economic analysis are very poor among delirium prevention trials.
Read the paper here: Effectiveness of drug interventions to prevent delirium after surgery for older adults: systematic review and network meta-analysis of randomised controlled trials | The BMJ
© 2026 Global Fragility Fracture Network | All Rights Reserved I Designed by Aaron Knight